The downside of downsizing: playing it safe

"Gone are the people who acquired the experience to know what doesn't work... Those with sufficient boldness to try something outside the conventional axioms now spend their mornings expanding their LinkedIn contacts," laments Daniel Hoffman, president at Pharmaceutical Business Research Associates, in Pharmalot. The result? Politically savvy, play-it-safe employees, those least likely to drive the changes needed to get pharma growing again. Op-Ed

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.